Amylyx Pharmaceuticals, Inc.

AMLX·NasdaqGS·Healthcare
Compare
27.48−0.66 (−2.35%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD
After hours27.480.00 (0.00%)Oct 12, 4:00 PM EDT

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close28.14
Open28.04
Day range27.4028.49
52-week range10.8341.14
Off day high−3.55%
Off 52-week high−33.20%
Volume1.11M
Avg. volume (3M)2.35M
Market cap3.45B
EPS (TTM)-1.41
Forward P/E-23.93
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)-0.09
Shares outstanding125.51M
Short interest12.64% of float
Earnings dateAug 6, 2026
Analyst target42.36
Profit margin0.00%

Against its peers

Compare in full ›
AMLX NBIX XERS AMRX ALKS BIOA
Market cap 3.45B 14.37B 1.91B 6.98B 6.75B 272.63M
P/E (TTM) — 20.7 — 40.9 105.9 —
Forward P/E -23.9 11.9 28.3 16.8 22.3 -2.4
Price/book 12.8 3.9 -186.8 194.5 3.7 0.7
Dividend yield — — — — — —
1-year change +93.66% +3.71% +31.82% +106.07% +25.15% +7.80%
Today −2.35% −0.75% −0.19% +0.60% −0.86% −6.31%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.

Related companies

Compare ›

Also based in Cambridge, Massachusetts, then elsewhere in Massachusetts.

Company Mkt cap Price Today
GE Vernova Inc.GEV · Cambridge, MA 265.48B 996.80 −0.79%
Moderna, Inc.MRNA · Cambridge, MAOdds 85.33B 213.74 −5.00%
Biogen Inc.BIIB · Cambridge, MA 33.90B 229.41 +1.64%
Alnylam Pharmaceuticals, Inc.ALNY · Cambridge, MAOdds 30.38B 227.02 −2.43%
Akamai Technologies, Inc.AKAM · Cambridge, MA 14.61B 101.65 −4.96%
HubSpot, Inc.HUBS · Cambridge, MA 11.43B 223.37 −2.16%
Scholar Rock Holding CorporationSRRK · Cambridge, MA 5.11B 41.94 −0.59%
Relay Therapeutics, Inc.RLAY · Cambridge, MA 3.94B 17.98 +0.56%

The stocks whose daily moves over the past year went most closely with Amylyx Pharmaceuticals's: the correlation of their daily returns, where 1 would be moving as one.

Company Mkt cap Price Today
4D Molecular Therapeutics, Inc.FDMT · Correlation 0.43 718.17M 13.00 −2.48%
Beam Therapeutics Inc.BEAM · Correlation 0.39 2.60B 25.13 −2.22%
Recursion Pharmaceuticals, Inc.RXRX · Correlation 0.39 2.15B 4.0100 −8.03%
Relay Therapeutics, Inc.RLAY · Correlation 0.38 3.94B 17.98 +0.56%
IDEAYA Biosciences, Inc.IDYA · Correlation 0.38 3.48B 36.06 −0.14%
Mineralys Therapeutics, Inc.MLYS · Correlation 0.37 1.97B 22.23 −4.88%
Scholar Rock Holding CorporationSRRK · Correlation 0.36 5.11B 41.94 −0.59%
Arcutis Biotherapeutics, Inc.ARQT · Correlation 0.36 3.30B 26.22 −1.35%

What visitors to Amylyx Pharmaceuticals's page also look at.

Company Mkt cap Price Today
4D Molecular Therapeutics, Inc.FDMT 718.17M 13.00 −2.48%
Arcutis Biotherapeutics, Inc.ARQT 3.30B 26.22 −1.35%
Taysha Gene Therapies, Inc.TSHA 1.35B 4.1400 −7.80%
Edgewise Therapeutics, Inc.EWTX 4.18B 38.45 −1.56%
Stoke Therapeutics, Inc.STOK 1.56B 24.15 −2.38%

From the 4Search instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 15 min.

Latest news

All AMLX news ›

From articles in the 4Search news index.

In the news

7mentions in 30 days
7with it in the headline
Mixedsentiment

Mentioned with

Guggenheim Securities4Leerink Partners Llc4Morgan Stanley4Amylyx3Eli Lilly3Eloxx Pharmaceuticals, Inc3J.p Morgan Securities Llc3Leerink Partners3

People in the coverage

Amylyx3James Condulis2Kamal Choudhury2Marilyn Tan2Nobuo Sayama2Adam Jonas1

Themes

Pharmaceuticals5Biotechnology3Equities3Guggenheim Securities3Leerink Partners3Lock-Up3Lock-Up Agreement3Morgan Stanley3

Most coverage from

  1. marketscreener.com3
  2. biospace.com1
  3. stocktitan.net1
  4. themarketsdaily.com1
  5. tradingview.com1

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 7 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.